Finance

Beta
Lists
DRMA:NASDAQ
Dermata Therapeutics Inc
$1.21
+2.54%
(+0.030) 1D
$1.21
0.00% (0.00)
Pre-market
Closed: Jun 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DRMA...
Open
$1.21
High
$1.24
Low
$1.18
Mkt. cap
4.87M
Avg. vol.
58.61K
Volume
517.00
52-wk high
$8.00
52-wk low
$1.10
EPS
-$5.43
Beta
0.69
Shares outstanding
4.02M
No. of employees
9
Open
$1.21
High
$1.24
Low
$1.18
Mkt. cap
4.87M
Avg. vol.
58.61K
Volume
517.00
52-wk high
$8.00
52-wk low
$1.10
EPS
-$5.43
Beta
0.69
Shares outstanding
4.02M
No. of employees
9
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to DRMA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for DRMA in the last 3 months.
Highest
Current $1.21
$4.00 (+230.58%)
Average
$4.00 (+230.58%)
Lowest
$4.00 (+230.58%)
News stories
From sources across the web
About Dermata Therapeutics Inc
CEO-
Employees9
Founded2014
Headquarters-
SectorBiotechnology
Websitedermatarx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
617.84K
504.39K
526.62K
383.72K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.15M
1.26M
1.37M
1.54M
Operating expense
1.77M
1.76M
1.90M
1.93M
Total operating expenses
1.77M
1.76M
1.90M
1.93M
Operating income
-1.77M
-1.76M
-1.90M
-1.93M
Other non operating income
-
-
-
-
EBT including unusual items
-1.70M
-1.69M
-1.86M
-1.85M
EBT excluding unusual items
-1.70M
-1.69M
-1.86M
-1.85M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.70M
-1.69M
-1.86M
-1.85M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
71.64K
68.68K
38.50K
78.68K
Interest expense
-
-
-
-
Net interest expenses
71.64K
68.68K
38.50K
78.68K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer